Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garth Powis

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Organic & Biomolecular Chemistry|July 1, 2004
Synthesis and biological evaluation of synthetic viridins derived from C(20)-heteroalkylation of the steroidal PI-3-kinase inhibitor wortmanninPeter Wipf, Daniel J Minion, Robert J Halter, et al.
Molecular Cancer Therapeutics|September 20, 2005
The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non-small cell lung cancer xenograftsNathan T Ihle, Gillian Paine-Murrieta, Margareta I Berggren, et al.
Bioorganic & Medicinal Chemistry|March 1, 2011
Development of sulfonamide AKT PH domain inhibitorsAli Md Ahad, Song Zuohe, Lei Du-Cuny, et al.
Neuro-Oncology|February 17, 2010
Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastomaDimpy Koul, Ruijun Shen, Yong-Wan Kim, et al.
Nature Communications|May 18, 2016
ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogationPetrus R de Jong, Koji Taniguchi, Alexandra R Harris, et al.
Oncology Research|November 24, 2004
In vivo molecular pharmacology and antitumor activity of the targeted Akt inhibitor PX-316Emmanuelle J Meuillet, Nathan Ihle, Amanda F Baker, et al.
Pancreas|April 1, 2008
Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancerAmanda F Baker, Mei Y Koh, Ryan R Williams, et al.
Cancer Research|November 26, 2014
Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinomaMei Yee Koh, Vuvi Nguyen, Robert Lemos, et al.
International Journal of Cancer|May 18, 2010
Combined action of the dinuclear platinum compound BBR3610 with the PI3-K inhibitor PX-866 in glioblastomaHo-Shin Gwak, Takashi Shingu, Vaibhav Chumbalkar, et al.
Molecular Pharmacology|April 20, 2006
OSU-03012 promotes caspase-independent but PERK-, cathepsin B-, BID-, and AIF-dependent killing of transformed cellsAdly Yacoub, Margaret A Park, David Hanna, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Organic & Biomolecular Chemistry|July 1, 2004
Synthesis and biological evaluation of synthetic viridins derived from C(20)-heteroalkylation of the steroidal PI-3-kinase inhibitor wortmanninPeter Wipf, Daniel J Minion, Robert J Halter, et al.
Molecular Cancer Therapeutics|September 20, 2005
The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non-small cell lung cancer xenograftsNathan T Ihle, Gillian Paine-Murrieta, Margareta I Berggren, et al.
Bioorganic & Medicinal Chemistry|March 1, 2011
Development of sulfonamide AKT PH domain inhibitorsAli Md Ahad, Song Zuohe, Lei Du-Cuny, et al.
Neuro-Oncology|February 17, 2010
Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastomaDimpy Koul, Ruijun Shen, Yong-Wan Kim, et al.
Nature Communications|May 18, 2016
ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogationPetrus R de Jong, Koji Taniguchi, Alexandra R Harris, et al.
Oncology Research|November 24, 2004
In vivo molecular pharmacology and antitumor activity of the targeted Akt inhibitor PX-316Emmanuelle J Meuillet, Nathan Ihle, Amanda F Baker, et al.
Pancreas|April 1, 2008
Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancerAmanda F Baker, Mei Y Koh, Ryan R Williams, et al.
Cancer Research|November 26, 2014
Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinomaMei Yee Koh, Vuvi Nguyen, Robert Lemos, et al.
International Journal of Cancer|May 18, 2010
Combined action of the dinuclear platinum compound BBR3610 with the PI3-K inhibitor PX-866 in glioblastomaHo-Shin Gwak, Takashi Shingu, Vaibhav Chumbalkar, et al.
Molecular Pharmacology|April 20, 2006
OSU-03012 promotes caspase-independent but PERK-, cathepsin B-, BID-, and AIF-dependent killing of transformed cellsAdly Yacoub, Margaret A Park, David Hanna, et al.
Pageof 10